D. Western Therapeutics Institute (4576 JP) - News Flash - November 19, 2024
DWTI announced topline results from its Phase 2B clinical trial of its H-1337 Ophthalmic Solution, for the treatment of elevated intraocular...
134 Views
D. Western Therapeutics Institute (4576 JP) - News Flash - Sep 5, 2024
DWTI announced that the first transplant was performed in a domestic Phase II clinical study of DWR-2206 (Indication: bullous keratopathy)
178 Views
D. Western Therapeutics Institute (DWTI) (4576 Jp) - 2Q Follow-Up
DWTI held a 1H results briefing via ZOOM webinar on Friday 8/23 at 13:30, hosted by President Hidaka. Several important points came up in his...
195 Views
D. Western Therapeutics Institute (4576 JP) - News Flash
The number of patients is 200 cases in 4 groups: H-1337 0.6% (twice daily), 1.0% (twice daily), 1.0% (once daily), and Timolol (beta blocker drug...
372 Views
D. Western Therapeutics Institute (DWTI) (4576 JP) - New Fundraising Secured in June
in Japan, start P2 clinical trials in 2024, P3 trials in late 2025 though 2026, and normal schedule application for approval for regenerative cell...
72 Views